SVA.TO Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: June 25, 2025
Report Source: 2025 2nd Quarter Report
Sernova Biotherapeutics Inc. Stock Analysis SVA.TO
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 8 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Read More Sernova Biotherapeutics Inc (SVA.TO) Chart
Key Statistics of Sernova Biotherapeutics Inc (SVA.TO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.16Volume
32.72KP/E Ratio (TTM)
-52 Week Range
Market Cap
59.11MAvg. Volume
143.12KDividend Yield
-Financial Metrics & Statements of Sernova Biotherapeutics Inc (SVA.TO)
FAQ's for Sernova Biotherapeutics Inc (SVA.TO)
- According to Musaffa’s Shariah screening methodology, Sernova Biotherapeutics Inc (SVA.TO) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.